Brexit could cause fatal delays for cancer patients who need urgent treatment, experts warn Brexit could prevent cancer patients from being treated in time, if supplies of radioactive materials used in treatments and scans are disrupted by leaving the European civil nuclear regulator, Euratom, experts have warned.
Senior NHS oncologists and radiologists told the Lords EU Home Affairs Subcommittee today that close to a million patients receive radiotherapies or scans that largely depend on EU manufacturers.
Many of these treatments are time sensitive and delays or disruption "significantly diminish" the likelihood that a cancer can be cured, the committee heard. The Independent
Senior NHS oncologists and radiologists told the Lords EU Home Affairs Subcommittee today that close to a million patients receive radiotherapies or scans that largely depend on EU manufacturers.
Many of these treatments are time sensitive and delays or disruption "significantly diminish" the likelihood that a cancer can be cured, the committee heard. The Independent
No comments:
Post a Comment